USPTO 2015–2025 USPTO PatentsView US Corporation

Healbe Corporation

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Healbe ranks #47,355 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#47,355
of 49,997 US assignees by volume
9th percentile
by Innovation Score (22.0/100)
8.2
avg claims per patent
+50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47355 · US Corporation #47,355 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #47,355/49,997
  • PHOTO-FINISH HDL Therapeutics
  • CPC-NARROW A61B · 6 areas
  • INNOV-THIN 22.0/100
  • CLAIMS-PAR 8.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: HDL Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Healbe’s 22.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Healbe

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Healbe's Innovation Score is 22.0/100 (9th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Healbe?

Each dot is one of Healbe’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Healbe’s own 8.2 claims/patent is at or below the 16.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Healbe vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 010203040 Granted patents (volume) Avg claims / patent HDL Therapeutics, Inc. - 5, 16.6HDL TherapeuticsHdpe Solutions, LLC - 5, 10.4Hdpe SolutionsHDR LLC - 5, 15.2HDRHeadwaters Heavy OIL, LLC - 5, 36.2Headwaters Heavy…Health-ever Biotech Co. Ltd - 5, 16.6Health-ever Biote…Healthbeacon, Ltd. - 5, 6.2HealthbeaconHealthpointe Solutions, Inc. - 5, 19Healthpointe Solu…Hearing Components, Inc. - 5, 22.8Hearing ComponentsHealbe Corporation - 5, 8.2Healbe
Healbe vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Healbe's grants concentrate

Healbe Corporation is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Healbe sits between HDL Therapeutics, Inc. and Hearing Components, Inc..

Healbe's three-year grant acceleration

Healbe Corporation shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Healbe's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Healbe holds 5 patents at rank #47,327, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Healbe

By rank, the assignees closest to #47,327 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Healbe's primary technology class.

Healbe's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

22 9th percentile higher than 9% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1 20182019202020212022 1
USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Healbe Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 20.0%
2019 1 20.0%
2020 1 20.0%
2021 1 20.0%
2022 1 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Healbe Corporation's patent record in context - here's where to go next.

  • Healbe Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #47,355 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Healbe Corporation against HDL Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 22.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.